
About Perfusio
Perfusio is a company based in Greenville (United States) founded in 2014. Perfusio has raised $7.79 million across 9 funding rounds from investors including HHS. Perfusio offers products and services including Certes. Perfusio operates in a competitive market with competitors including Haemonetics, VISIE, Sisu Global Health, Haermonics and i-sep, among others.
- Headquarter Greenville, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website perfusio.com
- Social LinkedIn
- Total Equity Funding$7.79M (USD)
in 9 rounds
- Latest Funding Round$2.2M (USD), Seed
Nov 2024
- Investors
Products & Services of Perfusio
Perfusio offers a comprehensive portfolio of products and services, including Certes.
Provides real-time visualization of blood flow and tissue integrity in surgery.
Funding Insights of Perfusio
Perfusio has successfully raised a total of $7.79M across 9 strategic funding rounds. The most recent funding activity was a Seed round of $2.2 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.79M
- Total Rounds 9
- Last Round Seed β $2.2M
- First Round $2M
(Sep 2016)
- Investors Count 1
All 9 funding rounds of Perfusio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $2.2M | Seed | β | β | β |
| Jul 2022 | $1.6M | Seed | β | β | β |
| Sep 2021 | $259,590 | Grant | β | β | |
| Aug 2020 | $2M | Series A | β | β | β |
| Nov 2019 | $1.48M | Grant | β | β | β |
| Sep 2019 | $224,841 | Grant | β | β | |
| Mar 2019 | $868,741 | Debt – Conventional | β | β | β |
| Aug 2017 | $1.68M | Grant | β | β | |
| Sep 2016 | $2M | Angel Round | β | β | β |
1 investors in total: 1 institutional.
Investors in Perfusio
Perfusio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Perfusio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Perfusio
16 people are tracked at Perfusio (5 in leadership, 11 in board & advisors).
| Name | Role | Group |
|---|---|---|
Monte B Tucker | CEO | Leadership |
Phil Hodges | CEO | Leadership |
Peter Geiger | CFO | Leadership |
Cheng Chen | Chief Science & Technical Officer, Co-Founder | Leadership |
Joffre Alvarez | Director, Operations | Leadership |
George McGinn | Board Member | Board & advisors |
Rich Balot | Board Member | Board & advisors |
David B. Leeser | Advisor | Board & advisors |
Ashesh N. Buch | Advisor | Board & advisors |
David LaVance | Board Member | Board & advisors |
Mark A. Farber | Advisor | Board & advisors |
Kenichi Matsumura | Board Member | Board & advisors |
Steve Taylor | Board Member | Board & advisors |
Mercedes Dullum | Advisor | Board & advisors |
John M. Prager | Advisor | Board & advisors |
Bruce Ferguson | Director | Board & advisors |
Complete people profiles for Perfusio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Perfusio
3 dated milestones of Perfusio across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Perfusio is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Seed, of $2.2M.
Competitors of Perfusio
Perfusio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, VISIE, Sisu Global Health, Haermonics and i-sep, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| haemonetics.com | 1971 | Braintree, United States | – | 3,034 | Hematology products and solutions are provided for medical applications. | |
| visievision.com | 2017 | Austin, United States | $12.71M | – | Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery | |
| sisuglobal.health | 2014 | Baltimore, United States | – | – | Intraoperative autotransfusion devices are developed and provided. | |
| haermonics.com | 2015 | Amsterdam, Netherlands | $4.41M | – | Postoperative pericardial drainage and flushing system is developed. | |
| i-sep.com | 2015 | Nantes, France | $3.61M | – | Cell salvage solutions for autologous blood transfusion during surgery | |
| procellsi.com | 2015 | Canton, United States | – | – | Develops medical devices for intraoperative blood recovery and conservation. | |
| swabtech.co.uk | 2012 | Manchester, United Kingdom | $938,127 | – | Offers a device for intra-operative blood recovery from swabs. | |
| gatescience.com | 2020 | Boston, United States | $150,000 | – | Developer of a multi-modal device for post-surgery pain | |
| scinovia.com | 2014 | Durham, United States | $6.91M | 10 | Augmented-reality surgical cameras for blood flow visualization are developed. | |
| bonvisi.com | 2013 | Nacka, Sweden | – | – | Endoscopic pump systems for urological procedures are manufactured by Bonvisi. |
Detailed competitors of Perfusio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Perfusio
Complete news archive for Perfusio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Perfusio
10 companies that operate in the same segment as Perfusio (Medical Equipment & Supplies), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Software and integrated solutions for surgical and radiotherapy applications | 1989 | Munchen, Bayern, Germany | USD 12.68 M | USD 1.18 M | 18 | |
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Collaborative surgical robotic systems are provided for hospital procedures. | 2014 | Cambridge, Cambridgeshire, United Kingdom | USD 1.32 B | – | – | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.17 M | – | 242 | |
Augmented reality systems for guiding surgical procedures are developed. | 2014 | Yokneam Illit, North District, Israel | USD 142.6 M | – | – | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | – | USD 3.07 B | 10,600 | |
Rapid infusion systems are provided for critically ill patients. | 2012 | Durham, North Carolina, United States | USD 77.98 M | – | – | |
Mobile robots are manufactured for industries including healthcare and agriculture. | 2013 | Odense, Denmark | USD 81.44 M | – | 303 | |
Visualization systems for surgical procedures are developed using machine learning. | 2016 | Seattle, Washington, United States | USD 74.25 M | – | 52 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Perfusio
Perfusio was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Perfusio is headquartered in Greenville, United States.
Monte B Tucker is the current CEO of Perfusio.
Perfusio is a funded company, having raised a total of $7.79M across 9 funding rounds to date. The company's 1st funding round was a Angel Round of $2M, raised on Sep 2016.
A blood-flow imaging device known as Certes was developed by Perfusio, founded in 2014 and based in Greenville, United States. Real-time visualization of blood flow and perfusion in vascular structures and tissues is provided during surgeries. Complications in procedures are reduced through hemoglobin flow monitoring. Operations focus on medical imaging technology within the healthcare sector, serving surgical applications across the region.
Perfusio's top competitors include Haemonetics, VISIE and Sisu Global Health.
Perfusio offers Certes.
Perfusio has 1 investor. Key investors include HHS.
